Tangible Shareholders Equity: The value shareholders equity less intangible assets.
TherapeuticsMD, Inc. (TXMD) had Tangible Shareholders Equity of $24.16M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$1.26M |
|
$0.49M |
|
-- |
|
$1.26M |
|
$1.74M |
|
$-0.48M |
|
$0.98M |
|
$0.50M |
|
$0.50M |
|
$0.50M |
|
$0.50M |
|
$0.49M |
|
$0.50M |
|
$-0.48M |
|
$0.32M |
|
11.57M |
|
11.64M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$17.42M |
|
-- |
|
$20.52M |
|
$37.93M |
|
$5.25M |
|
-- |
|
$5.06M |
|
$10.31M |
|
$27.62M |
|
|
Tangible Shareholders Equity |
$24.16M |
$27.62M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$2.99M |
|
-- |
|
-- |
|
$7.48M |
|
$10.45M |
|
$2.96M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-38.05% |
|
-38.05% |
|
-- |
|
39.79% |
|
39.00% |
|
$2.99M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.37 |
|
243.91 |
|
1.81% |
|
2.07% |
|
1.32% |
|
1.81% |
|
$2.39 |
|
$0.26 |
|
$0.26 |
|